A key claim by the company MedTherapy is a major reduction in production timelines. While gene therapies typically take weeks ...
With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine One of the more exciting opportunities in medical ...
Beta thalassemia major, also known as Cooley’s anemia and transfusion-dependent beta thalassemia, causes the body’s red blood ...
A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...
What Is Kresladi, and Why Does It Matter? Kresladi (marnetegragene autotemcel) is a gene therapy approved by the FDA to treat a rare and serious immune condition called leukocyte adhesion deficiency ...
Researchers found that SynCav1 strengthened neuron resilience, preserved brain signaling, and improved cognitive function in ...
Russian scientists are reportedly developing a world-first gene therapy targeting the RAGE receptor to halt cellular aging. Linked to Vladimir Putin's goal of a 150-year lifespan, the project involves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results